I A C P Life on the the lead lobbyist for the International Academy of CompoundingI’m often asked what the typical day is like in Washington,D.C. AsHillorganization specifically representingonlyPharmacists (IACP), thethe interests of compounding pharmacists in the United Statesand abroad, no day is really ever the same. IACP currently IACP’s Sarah Dodge, represents more than 2,700 compounding pharmacists, Vice President of Government Affairs, pharmacy technicians, students and members of the compounding community as well as more than 164,000 patients Describes a Typical Day in D.C. and practitioners comprising IACP’s Patients and Professionals for Customized Care (P2C2) advocacy organization. Our issues are varied and often complex, and can change on a daily basis. On most any day,I usually get to my desk (usually after attending a fundraising breakfast or a candidate meet and greet first thing in the morning) and immediately begin checking voicemail messages and reviewing 50 to 100 new e-mails. I’ll spend almost half the day on the phone discussing issues related to compounding pharmacy with everyone from Members of Congress, Hill staff, agency officials, other professional organizations to IACP Members. These issues may include: FDA policies; DEA policies; and legislative proposals which could potentially impact the practice of compounding pharmacy and general practice issues. Sometimes, my schedule can change drastically and I have to be willing and ready to roll with the punches. In addition to attending regularly scheduled Hill appointments, I’m always prepared to go to the Hill at a moment's notice if there is an immediate need to address Congressional activity or potential Congressional inquiries. Congressional staffers will want to discuss current issues just as much as those in our compounding arena. “Where does IACP stand on online pharmacy safety legislation? What do IACP Members think about dietary supplement legislation or requirements for veterinarian scripts? What are the pros and cons of certain positions? How does IACP feel about recent reports of drug shortages and how can IACP Members help?” Sometimes answering those questions requires doing further in-depth research and also may entail discussing policy with other pharmacy organizations to gauge their positions. 26 I A C P C U S T O M Rx C O N N E C T I O N I A C P R X . O R G
Custom Rx Connection August 2012
To see the actual publication please follow the link above